Hangzhou Biotest Biotech Co.,Ltd.

Rachunek Zysków i Strat





Wskaźnik 6 5 4 3 2 1 0 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Data sprawozdania 2017-12-31 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Okres FY FY FY FY FY FY FY FY
Przychód (mln) 122 180 209 865 1 818 1 901 442 559
Przychód Δ r/r 0.0% 48.1% 15.8% 314.4% 110.1% 4.6% -76.7% 26.5%
Marża brutto 38.4% 38.5% 42.8% 74.8% 61.8% 53.5% 100.0% 52.8%
EBIT (mln) 4 23 32 513 967 914 122 193
EBIT Δ r/r 0.0% 429.1% 43.0% 1491.9% 88.4% -5.4% -86.7% 58.9%
EBIT (%) 3.5% 12.5% 15.4% 59.3% 53.2% 48.1% 27.5% 34.6%
Koszty finansowe (mln) 1 1 1 0 1 0 0 2
EBITDA (mln) 13 35 41 529 994 994 122 218
EBITDA(%) 10.5% 19.2% 19.6% 61.1% 54.7% 52.3% 27.5% 38.9%
Podatek (mln) 1 4 4 79 133 128 121 28
Zysk Netto (mln) 4 19 28 435 834 774 0 170
Zysk netto Δ r/r 0.0% 369.0% 49.3% 1441.5% 91.6% -7.2% -100.0% inf%
Zysk netto (%) 3.3% 10.5% 13.5% 50.3% 45.9% 40.7% 0.0% 30.3%
EPS 0.05 0.24 0.26 4.08 7.81 7.25 0.0 1.61
EPS (rozwodnione) 0.05 0.24 0.26 4.08 7.81 7.25 0.0 1.61
Ilośc akcji (mln) 81 79 107 107 107 107 107 105
Ważona ilośc akcji (mln) 81 79 107 107 107 107 107 105
Waluta CNY CNY CNY CNY CNY CNY CNY CNY